Effectiveness of the rare pediatric disease priority review voucher program
Feature ArticlesRahul Chandrasekhar, PhD, RAC
Biologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsFeature ArticlesRahul Chandrasekhar, PhD, RACBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticals